Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer.
Prober
C G
CG
Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, California, USA.
Wang
E E
EE
D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007223:Infant; D018357:Respiratory Syncytial Virus Infections / Q000628:therapy*; D012141:Respiratory Tract Infections / Q000628:therapy*; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D016756:Immunoglobulins, Intravenous; D012254:Ribavirin